All Studies

Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.

Chinese herbal medicines, including Corilagin, have been found to exhibit important antiviral activities against various viruses. While vaccines and drugs may not be effective in preventing the COVID-19 pandemic due to coronavirus mutations, exploring the use of herbal medicines may provide an alternative solution. Corilagin has shown antiviral effects on HIV, HCV, and EBV but its ability to block the interaction between SARS-CoV-2 and hACE2 has not been determined. Further research may reveal the potential of Corilagin as a COVID-19 treatment.

Yang LJ et al (2021).
Phytomedicine.
PubMed:
34029937